Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle Scurr

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Sarcoma|June 8, 2011
Targeting the Insulin-Like Growth Factor 1 Receptor in Ewing's Sarcoma: Reality and ExpectationsDavid Olmos, Ana Sofia Martins, Robin L Jones, et al.
American Journal of Clinical Oncology|March 23, 2011
Role of palliative chemotherapy in advanced epithelioid sarcomaRobin L Jones, Anastasia Constantinidou, David Olmos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2014
Phase II study of cediranib in patients with advanced gastrointestinal stromal tumors or soft-tissue sarcomaIan Judson, Michelle Scurr, Kate Gardner, et al.
Sarcoma|May 29, 2010
Clinical benefit of second-line palliative chemotherapy in advanced soft-tissue sarcomaAnna Minchom, Robin L Jones, Cyril Fisher, et al.
Journal of Gastroenterology and Hepatology|April 3, 2016
Short bowel syndrome (SBS)-associated alterations within the gut-liver axis evolve early and persist long-term in the piglet model of short bowel syndromePrue M Pereira-Fantini, Julie E Bines, Susan Lapthorne, et al.
Clinical Sarcoma Research|May 20, 2015
A phase II trial to assess the activity of gemcitabine and docetaxel as first line chemotherapy treatment in patients with unresectable leiomyosarcomaBeatrice Seddon, Michelle Scurr, Robin L Jones, et al.
Cancer Chemotherapy and Pharmacology|November 12, 2010
Clinical benefit of early phase clinical trial participation for advanced sarcoma patientsRobin L Jones, David Olmos, Khin Thway, et al.
Cancer Chemotherapy and Pharmacology|December 14, 2004
Imatinib pharmacokinetics in patients with gastrointestinal stromal tumour: a retrospective population pharmacokinetic study over time. EORTC Soft Tissue and Bone Sarcoma GroupIan Judson, Peiming Ma, Bin Peng, et al.
World Journal of Gastroenterology|April 21, 2015
Changes in the colon microbiota and intestinal cytokine gene expression following minimal intestinal surgerySusan Lapthorne, Julie E Bines, Fiona Fouhy, et al.
Development (Cambridge, England)|March 9, 2019
Kidney micro-organoids in suspension culture as a scalable source of human pluripotent stem cell-derived kidney cellsSanthosh V Kumar, Pei X Er, Kynan T Lawlor, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Sarcoma|June 8, 2011
Targeting the Insulin-Like Growth Factor 1 Receptor in Ewing's Sarcoma: Reality and ExpectationsDavid Olmos, Ana Sofia Martins, Robin L Jones, et al.
American Journal of Clinical Oncology|March 23, 2011
Role of palliative chemotherapy in advanced epithelioid sarcomaRobin L Jones, Anastasia Constantinidou, David Olmos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2014
Phase II study of cediranib in patients with advanced gastrointestinal stromal tumors or soft-tissue sarcomaIan Judson, Michelle Scurr, Kate Gardner, et al.
Sarcoma|May 29, 2010
Clinical benefit of second-line palliative chemotherapy in advanced soft-tissue sarcomaAnna Minchom, Robin L Jones, Cyril Fisher, et al.
Journal of Gastroenterology and Hepatology|April 3, 2016
Short bowel syndrome (SBS)-associated alterations within the gut-liver axis evolve early and persist long-term in the piglet model of short bowel syndromePrue M Pereira-Fantini, Julie E Bines, Susan Lapthorne, et al.
Clinical Sarcoma Research|May 20, 2015
A phase II trial to assess the activity of gemcitabine and docetaxel as first line chemotherapy treatment in patients with unresectable leiomyosarcomaBeatrice Seddon, Michelle Scurr, Robin L Jones, et al.
Cancer Chemotherapy and Pharmacology|November 12, 2010
Clinical benefit of early phase clinical trial participation for advanced sarcoma patientsRobin L Jones, David Olmos, Khin Thway, et al.
Cancer Chemotherapy and Pharmacology|December 14, 2004
Imatinib pharmacokinetics in patients with gastrointestinal stromal tumour: a retrospective population pharmacokinetic study over time. EORTC Soft Tissue and Bone Sarcoma GroupIan Judson, Peiming Ma, Bin Peng, et al.
World Journal of Gastroenterology|April 21, 2015
Changes in the colon microbiota and intestinal cytokine gene expression following minimal intestinal surgerySusan Lapthorne, Julie E Bines, Fiona Fouhy, et al.
Development (Cambridge, England)|March 9, 2019
Kidney micro-organoids in suspension culture as a scalable source of human pluripotent stem cell-derived kidney cellsSanthosh V Kumar, Pei X Er, Kynan T Lawlor, et al.
Pageof 4